Every baby born in the United States is given a routine blood test to screen for dozens of inherited medical conditions. Now, the U.S. National Institutes of Health is exploring whether to use DNA ...
Missing documentation of CF carrier screening history for a significant number of patients and incomplete data transfer will likely be problematic for the birth hospital completing the NBS form and ...
When a baby is born in the United States, a few drops of blood are taken from their heel to test for many conditions that could affect the child’s long-term health or survival. This testing is part of ...
Every newborn undergoes screening in their first few days of life. It is a quick routine that mostly brings peace of mind. But for a small number of families, the results can be abnormal. An abnormal ...
A committee of experts will conduct a study examining the current landscape of newborn screening (NBS) systems, processes, and research in the United States and consider sustainable adoption of ...
The United States Cystic Fibrosis Foundation released the first guideline on newborn screening for cystic fibrosis (CF), in order to improve timely detection of CF in infants from all racial and ...
Nearly all of the approximately 4 million newborns in the United States undergo screening within the first few days of life, primarily through evaluation of dried blood spots for a wide variety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback